ClinicalTrials.Veeva

Menu

Effects on Organ Damage and Surgical Outcome of a New Cardiopulmonary Pass System (EVADO)

I

IRCCS San Raffaele Roma

Status

Completed

Conditions

C.Surgical Procedure; Cardiac

Treatments

Device: Conventional CPB
Device: EVADO

Study type

Interventional

Funder types

Other

Identifiers

NCT01805466
GR-2009-1591573

Details and patient eligibility

About

The primary purpose of this study is to assess the effects of the use of EVADO with respect to a conventional cardio-pulmonary bypass (CBP) system on surgical morbidity and mortality. As secondary aim this study wants to conduct appropriate laboratory investigations in order to detect the major biological mechanisms potentially responsible for the beneficial effects of the EVADO system on the coagulation cascade and inflammatory activation.

Full description

The present study is designed as a prospective, multicentre, randomized, open label, controlled, 2-arm parallel group, superiority trial.

Participating centres are selected based on previous experience with the use of the EVADO system.

Patients elected to open heart surgery for a variety of cardiac conditions related to coronary, valvular or aortic disease or their combination in the participating centers will be screened.

This study as secondary aim wants to confirm the results of earlier investigation by a multicentre trial conducted on a larger population of patients undergoing a wide spectrum of open heart cardiac operations and either assess a number of cost-efficacy-efficiency indicators.

Enrollment

300 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients elected to undergo open heart surgery for a variety of cardiac conditions related to coronary, valvular or aortic disease or their combination and fulfilling the following additional criteria:

  • Written informed consent
  • Age 18-85 years

Exclusion criteria

  • Severe renal or liver failure
  • Uncompensated diabetes
  • Autoimmune disease requiring immunosuppressant therapy
  • Coagulation disorders
  • Emergent or redo surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

300 participants in 2 patient groups

EVADO
Experimental group
Description:
The E.V.A.D.O. system is made of the following components: * The ADMIRAL oxygenator, that requires low priming volumes (, has a limited contact surface and contains an accessory independent cardiotomy reservoir, allowing separation of pericardial suction blood. * The HARMONY Smart Suction System, which allows automatic regulation of a pumpless extracavity blood sucker, whose rates and pressures depend on whether suction is required for blood/air surfaces (skimming), or for fluids (pooled). * Paediatric circuits with 3/8" tubing for both arterial and venous lines.
Treatment:
Device: EVADO
Conventional CPB
Active Comparator group
Description:
conventional cardiopulmonary by-pass (CPB) system
Treatment:
Device: Conventional CPB

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems